NCT06844669 2026-03-03
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy
Washington University School of Medicine
Phase 2 Active not recruiting
Clinical Trials
85 trialsNCT04044872 2026-02-02
Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Terminated
NCT06595147 2026-01-08
BE-FITTER
University of Alberta
Phase NA Recruiting
NCT06220032 2026-01-05
HO170DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3 Recruiting
NCT06023576 2026-01-02
A Study of Blood Pressure Control During Cancer Treatment
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT07254221 2025-12-10
ROSUBREAST
Shiraz University of Medical Sciences
Phase 4 Not yet recruiting
NCT04598646 2025-12-03
HIMALAYAS-P
University Health Network, Toronto
Phase NA Completed
NCT06183437 2025-12-03
STOP-MED
University Health Network, Toronto
Phase 4 Recruiting
NCT05023785 2025-11-26
HIMALAYAS
University Health Network, Toronto
Phase NA Recruiting
NCT05271162 2025-11-21
EMPACT
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 3 Recruiting
NCT03787966 2025-11-19
ATOPE
Universidad de Granada
Phase NA Completed
NCT05559164 2025-11-14
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Rutgers, The State University of New Jersey
Phase 2 Recruiting
NCT06155331 2025-08-19
Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Tanta University
Phase 2 Completed
NCT04892667 2025-08-13
DETECT
Assistance Publique - Hôpitaux de Paris
Phase NA Active not recruiting
NCT03862131 2025-07-29
PROACT
Washington University School of Medicine
Phase 2 Terminated
NCT04737265 2025-07-03
NTproBNP-Guide
Abramson Cancer Center at Penn Medicine
Phase 1/2 Completed
NCT05029154 2025-06-12
Exercise Preconditioning in Ovarian Cancer
University of Virginia
Phase NA Terminated
NCT05786014 2025-06-12
The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies
University of Virginia
Phase NA Completed
NCT06310330 2025-06-06
TRUST-ACE
Norwegian University of Science and Technology
Phase NA Recruiting
NCT06778122 2025-05-11
BREATHS
University College, London
Phase NA Recruiting
NCT06930521 2025-04-16
JUSTIFY
Women's College Hospital
Phase NA Not yet recruiting
NCT05406635 2025-04-08
HER2BIC
Odense University Hospital
Phase NA Recruiting
NCT04568161 2025-04-03
Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses
University of Sao Paulo General Hospital
Phase NA Completed
NCT03711110 2025-03-21
CARTIER
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Phase NA Recruiting
NCT06881940 2025-03-18
CARPTOX-BC
Instituto Nacional de Cardiologia Ignacio Chavez
Phase NA Not yet recruiting
NCT05465031 2025-03-14
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Silesian Centre for Heart Diseases
Phase 4 Recruiting
NCT05781672 2025-02-19
SpeckleAnthra2
University Hospital, Montpellier
Phase NA Terminated
NCT05403736 2025-02-06
CARMA
Cedars-Sinai Medical Center
Phase NA Completed
NCT05699915 2025-01-30
CAVACI
Algemeen Ziekenhuis Maria Middelares
Phase NA Terminated
NCT03934905 2024-11-20
Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction
Texas Tech University Health Sciences Center
Phase 1/2 Recruiting
NCT06684509 2024-11-12
Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia
Assiut University
Phase 1/2 Not yet recruiting
NCT05703126 2024-11-05
Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML
Samara State Medical University
Phase NA Recruiting
NCT04486573 2024-10-22
Cardiac Effects From Radiation Therapy by MRI
University of Colorado, Denver
Phase NA Completed
NCT06622954 2024-10-02
PROTECT-COR
Erasmus Medical Center
Phase NA Recruiting
NCT06595316 2024-09-19
Exercise for Ameliorating Chemotherapy Cardiotoxicity
University of Hull
Phase NA Not yet recruiting
NCT03748550 2024-08-21
EXACT2
Nova Scotia Health Authority
Phase NA Active not recruiting
NCT03486340 2024-07-08
CATCH
Vejle Hospital
Phase NA Completed
NCT04939883 2024-06-28
CardioTox
Hospital Sirio-Libanes
Phase 4 Unknown
NCT05467111 2024-04-11
CardioProtEx
Technical University of Madrid
Phase NA Recruiting
NCT06341842 2024-04-02
PROTECT
Fondazione IRCCS Policlinico San Matteo di Pavia
Phase 2 Recruiting
NCT06270667 2024-03-22
LYMfit
Norwegian School of Sport Sciences
Phase NA Recruiting
NCT06214195 2024-01-19
START
Zhejiang Cancer Hospital
Phase 3 Recruiting
NCT05923242 2024-01-11
ECHOS2
Washington University School of Medicine
Phase NA Completed
NCT06029166 2023-09-08
IRAF-ISCM
University Hospital, Caen
Phase NA Not yet recruiting
NCT06005259 2023-08-22
SPIROTOX
University of Sao Paulo
Phase 4 Unknown
NCT02881203 2023-07-27
BRAVEHeart
University of Sydney
Phase NA Completed
NCT05892146 2023-06-07
Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction
National Cheng-Kung University Hospital
Phase NA Unknown
NCT01719562 2023-05-19
MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum
Wake Forest University Health Sciences
Phase NA Completed
NCT05732051 2023-03-17
NARNIA
University Hospital, Akershus
Phase 2 Recruiting
NCT03850171 2023-02-27
Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study
Insel Gruppe AG, University Hospital Bern
Phase NA Terminated